[Effectiveness and costs of screening colonoscopy]

Area of Science:

• Gastroenterology
• Oncology
• Preventive Medicine

Context:

• Rectosigmoidoscopy revealing adenomas necessitates further colonoscopy due to doubled colorectal cancer risk.
• Genetic conditions like familial adenomatous polyposis (FAP), hereditary non-polyposis colorectal cancer (HNPCC), and hamartomatous polyposis syndromes increase colorectal carcinoma risk.
• Screening colonoscopies are also advised for relatives of individuals with familial 'sporadic' colon cancer and potentially for those with extensive ulcerative colitis.

Purpose:

• To outline the indications for screening colonoscopy and sigmoidoscopy.
• To emphasize the importance of follow-up after polyp removal and for high-risk genetic conditions.
• To discuss the benefits and considerations of population-wide screening from age 50.

Summary:

• Screening colonoscopy is indicated upon adenoma detection via rectosigmoidoscopy, with follow-up colonoscopies recommended every three years post-polyp removal.
• Individuals with genetic predispositions (FAP, HNPCC, hamartomatous polyposis) and first-degree relatives of familial 'sporadic' colon cancer patients benefit from repeated screening examinations.
• While screening colonoscopy/sigmoidoscopy for the general population over 50 is beneficial, cost-effectiveness requires consideration. Current recommendations include annual fecal occult blood tests supplemented by sigmoidoscopy every 3-5 years.

Impact:

• Highlights the critical role of colonoscopy in detecting colorectal cancer early, especially after adenoma identification.
• Underscores the necessity of tailored screening protocols for individuals with hereditary cancer syndromes.
• Provides guidance on population screening strategies, balancing benefits against costs and aligning with current expert recommendations.